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The full document of the first National Institute for Health and
Care Excellence (NICE) guideline on diagnosis andmanagement
of menopause1 recommends (page 18) that GPs should:
“Give information to menopausal women and their family
members or carers (as appropriate) about the following types
of treatment for menopausal symptoms:
• Hormonal, for example hormone replacement therapy
(HRT)
• Non-hormonal, for example clonidine
• Non-pharmaceutical, for example cognitive behavioural
therapy (CBT).”2
The evidence for CBT as a treatment for depressed mood and
anxiety is included in the guidance, but CBT has also been
developed to help women self manage vasomotor symptoms,
and this evidence is not provided. Group and self help CBT
have been shown to reduce the impact of these symptoms
significantly in three clinical trials with more than 600 women
(well women and women with breast cancer).3-5 Improvements
are maintained 26 weeks after randomisation, there are
additional benefits to quality of life, and no adverse effects were
reported. The treatment is brief and available in self help format,6
with a group manual available for health professionals.7
On the basis of this evidence, a recent position statement from
the North AmericanMenopause Society recommended CBT as
an effective non-hormonal management option for vasomotor
symptoms.8 Non-hormonal management of these symptoms is
an important consideration when hormone therapy is not an
option, because of either medical contraindications or a woman’s
personal choice.
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